Hepatitis C virus and human immunodeficiency virus coinfection in Spain (Q45016538)

8 December 2017

Hepatitis C virus and human immunodeficiency virus coinfection in Spain (English)

1 reference

8 December 2017

1 reference

14

1 reference

8 December 2017

Bernardino Roca

1

1 reference

8 December 2017

Ignacio Suarez

2

1 reference

8 December 2017

Juan Gonzalez

3

1 reference

8 December 2017

Myriam Garrido

4

1 reference

8 December 2017

Belen de la Fuente

5

1 reference

8 December 2017

Ramon Teira

6

1 reference

8 December 2017

Paloma Geijo

7

1 reference

8 December 2017

Jaime Cosin

8

1 reference

8 December 2017

Salvador Perez-Cortes

9

1 reference

8 December 2017

Maria Jose Galindo

10

1 reference

8 December 2017

Fernando Lozano

11

1 reference

8 December 2017

Pere Domingo

12

1 reference

8 December 2017

Pompeyo Viciana

13

1 reference

8 December 2017

Antonio Vergara

15

1 reference

8 December 2017

Trinitario Sánchez

16

1 reference

8 December 2017

1 August 2003

1 reference

8 December 2017

1 reference

8 December 2017

47

1 reference

8 December 2017

2

1 reference

8 December 2017

117-124

1 reference

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

An unequal epidemic in an unequal world

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

An investigation of why eligible patients do not receive HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

The HIV epidemic associated with injecting drug use in Europe: geographic and time trends.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Current situation and regional perspective on HIV/AIDS surveillance in europe

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

HCV and GBV-c/HGV infection in HIV positive patients in southern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Hepatitis C in HIV-infected patients--therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Reducing social vulnerability to HIV/AIDS: models of care and their impact in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Sexual transmission of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Hepatitis C and progression of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

Research potentials and pitfalls in the use of an HIV clinical database: Chelsea and Westminster Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900067-7

7 January 2021

10.1016/S0163-4453(03)00067-7

Identifiers

DOI

1 reference

8 December 2017

1 reference